Company · CIK 0001070494 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
ACADIA PHARMACEUTICALS INC · ACAD
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 SForm 4 → | Aug 7, 6:00 pm EDT | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | 20,141 | $29.16 | $587,242 | 67,828 | −22.9% | 10b5-1 |
| Aug 5, 2026 MForm 4 → | Aug 7, 6:00 pm EDT | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | 20,141 | $17.84 | $359,315 | 82,120 | — | 10b5-1 |
| Jul 30, 2026 SForm 4 → | Jul 31, 6:00 pm EDT | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | 16,558 | $26.13 | $432,663 | 18,994 | −46.6% | |
| Jul 29, 2026 MForm 4 → | Jul 31, 6:00 pm EDT | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | 32,272 | — | — | 35,552 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 MForm 4 → | Aug 7, 6:00 pm EDT | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | 20,141 | — | — | 60,423 | — | 10b5-1 |
| Jul 29, 2026 MForm 4 → | Jul 31, 6:00 pm EDT | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | 32,272 | — | — | 32,272 | — |